TABLE 1.
Variable | Study (asthma) group (n = 131,937) | Control (non-asthma) group (n = 131,937) | SMD |
Sex | 0.01 | ||
Female | 60,464 | 60,972 | |
Male | 71,473 | 70,965 | |
Age, years | 6.25 (4.43) | 6.40 (4.52) | 0.06 |
0–5 | 65,587 | 65,057 | |
6–10 | 42,074 | 39,711 | |
11–17 | 24,276 | 27,169 | |
Economic status | 12.47 (5.62) | 12.40 (5.53) | 0.05 |
<20% | 16,537 | 15,850 | |
20–80% | 76,657 | 79,740 | |
>80% | 38,743 | 36,347 | |
Region | 0.06 | ||
Rural | 42,755 | 39,017 | |
Metro | 89,182 | 92,920 | |
Atopic dermatitis | 0.10 | ||
Yes | 29,198 | 23,834 | |
No | 102,739 | 108,103 | |
Allergic rhinitis | 0.03 | ||
Yes | 5,955 | 5,201 | |
No | 125,982 | 126,736 | |
CCI | 0.43 (0.56) | 0.38 (0.54) | 0.09 |
0 | 78,764 | 83,901 | |
1 | 50,389 | 46,109 | |
2 | 2,784 | 1,927 |
SMD, standardized mean difference and CCI, Charlson comorbidity index.